Concordance between treatment recommendations provided by IBM Watson for Oncology and a multidisciplinary tumor board for breast cancer in China.

Journal: Japanese journal of clinical oncology
Published Date: Aug 4, 2020

Abstract

OBJECTIVE: Watson for Oncology (WFO), an artificial intelligence from IBM Corporation, can provide a treatment plan by analyzing patient's disease characteristics. The present study was performed to examine the concordance between treatment recommendations proposed by WFO and the multidisciplinary tumor board at our center. The aim was to explore the feasibility of using WFO for breast cancer cases in China and to ascertain the ways to make WFO more suitable for Chinese patients with breast cancer.

Authors

  • Xiaoyao Zhao
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Yinbin Zhang
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Xingcong Ma
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Yinxi Chen
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Junfeng Xi
    Department of Thoracic surgery, Yulin City First Hospital Yulin Branch, Yulin, Shaanxi, China.
  • Xiaoran Yin
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Huafeng Kang
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Haitao Guan
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Zijun Dai
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Di Liu
    Laboratory of Nutrition and Functional Food, College of Food Science and Engineering, Jilin University, Changchun, China.
  • Fang Zhao
    St. John Fisher College, Rochester, NY, USA.
  • Chu Sun
    Medical Advisory Department, Hangzhou cognitive Network tech Co, Ltd., Hangzhou, Zhejiang, China.
  • Zongfang Li
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
  • Shuqun Zhang
    Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.

Keywords

External Resources

Popular Topics
Recent Journals